21 April 2023>: Original Paper
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
Chih-Hsien Cheng ABCDE , Hao-Chien Hung BC , Jin-Chiao Lee BC , Yu-Chao Wang CD , Tsung-Han Wu CD , Chen-Fang Lee ABC , Ting-Jung Wu BC , Hong-Shiue Chou BC , Kun-Ming Chan BC , Wei-Chen Lee ABCD*DOI: 10.12659/AOT.938731
Ann Transplant 2023; 28:e938731
Figure 3 Renal function change during therapy with TDF and TAFMedian (IQR) eGFR percentage change from baseline at weeks 24 and 48 during TDF and TAF treatment. n.s. not significant, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 (Wilcoxon paired test).